BRCA1 and breast cancer: In contrast, estrogen-plus-progestin or progestin-alone HRT following oophorectomy was associated with a significant increase in breast cancer risk in BRCA1 carriers (HR 3.38, 95% CI 1.17–9.73, P = 0.02).137